ID

34225

Description

Thalidomide fOr the Prevention of Restenosis After Coronary ArtERy Stent Implantation; ODM derived from: https://clinicaltrials.gov/show/NCT01638078

Link

https://clinicaltrials.gov/show/NCT01638078

Keywords

  1. 1/15/19 1/15/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 15, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Coronary Artery Disease NCT01638078

Eligibility Coronary Artery Disease NCT01638078

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
a de novo native coronary artery lesions (reference vessel diameter:2.5-3.75 mm)
Description

ID.1

Data type

boolean

class i indication to elective percutaneous coronary intervention
Description

ID.2

Data type

boolean

stable conditions and no recent acute coronary syndromes
Description

ID.3

Data type

boolean

normal baseline values of markers of myocardial damage (creatine kinase, creatine kinase-mb, myoglobin, and troponin i)
Description

ID.4

Data type

boolean

able to understand and willing to sign the informed cf
Description

ID.5

Data type

boolean

contraindications to des use (clinical history difficult to obtain, expected poor compliance with dapt, non-elective surgery required, increased risk of bleeding
Description

ID.6

Data type

boolean

allergy to asa or clopidogrel/prasugrel/ticagrelor, indication for long-term anticoagulation, large vessels, focal lesions)
Description

ID.7

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
women of child bearing potential patients must demonstrate a negative pregnancy test performed within 24 hours before ct
Description

ID.8

Data type

boolean

indications to des use (small vessels, long lesions diabetes, in-stent restenosis, complex lesions)
Description

ID.9

Data type

boolean

Similar models

Eligibility Coronary Artery Disease NCT01638078

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
a de novo native coronary artery lesions (reference vessel diameter:2.5-3.75 mm)
boolean
ID.2
Item
class i indication to elective percutaneous coronary intervention
boolean
ID.3
Item
stable conditions and no recent acute coronary syndromes
boolean
ID.4
Item
normal baseline values of markers of myocardial damage (creatine kinase, creatine kinase-mb, myoglobin, and troponin i)
boolean
ID.5
Item
able to understand and willing to sign the informed cf
boolean
ID.6
Item
contraindications to des use (clinical history difficult to obtain, expected poor compliance with dapt, non-elective surgery required, increased risk of bleeding
boolean
ID.7
Item
allergy to asa or clopidogrel/prasugrel/ticagrelor, indication for long-term anticoagulation, large vessels, focal lesions)
boolean
Item Group
C0680251 (UMLS CUI)
ID.8
Item
women of child bearing potential patients must demonstrate a negative pregnancy test performed within 24 hours before ct
boolean
ID.9
Item
indications to des use (small vessels, long lesions diabetes, in-stent restenosis, complex lesions)
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial